PATENT CLAIM ANALYSIS

Application Number: 15880160
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "257000"]

Abstract:
The present invention provides a method of treating patients in need of treatment with long acting injectable paliperidone palmitate formulations.

Claim (Index 48):
A dosing regimen for administering paliperidone palmitate to a psychiatric patient in need of treatment for schizophrenia, schizoaffective disorder, or schizophreniform disorder comprising\n (a) administering intramuscularly in the deltoid of a patient in need of treatment a first loading dose of about 150 mg-eq. of paliperidone as paliperidone palmitate formulated in a sustained release formulation on the first day of treatment; and (b) administering intramuscularly in the deltoid muscle of the patient in need of treatment a second loading dose of about 100 mg-eq. of paliperidone as paliperidone palmitate formulated in a sustained release formulation on the 6 th  to about 10 th  day of treatment.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.05
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12337144', '15090889', '14555273', '14555287', '13500623']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7162442951386626
- 35 USC 102 Novelty (BERT): 0.7242301059099201
- Combined Prediction Score: 0.7170428762157883
- Mean Citation Score: 425.511776
- Max Citation Score: 771.9951
- Similarity Product: 768.4841021014093

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test